IRTC241220P80000
- 0.40
- -0.75-65.22%
iRhythm Technologies Newsroom
J.P. Morgan Maintains IRhythm Technologies(IRTC.US) With Buy Rating, Raises Target Price to $97
IRhythm Technologies Is Maintained at Buy by Canaccord Genuity
CCORF Maintains IRhythm Technologies(IRTC.US) With Buy Rating, Raises Target Price to $152
Express News | IRhythm Technologies Inc : Canaccord Genuity Raises Target Price to $152 From $125
IRhythm Technologies Price Target Announced at $86.00/Share by Wells Fargo
IRhythm Technologies Analyst Ratings
Hold Rating on Irhythm Technologies Amid Regulatory Uncertainties and Growth Challenges
Morgan Stanley Maintains Positive MedTech Outlook Despite Setbacks in 2024, Upgrades Intuitive Surgical And Stryker, Downgrades Nevro And Glaukos
Wolfe's Most Shorted 'Hit List' – FSLR, BE, WBA, SJM
Does IRhythm Technologies (NASDAQ:IRTC) Have A Healthy Balance Sheet?
DexCom Pairs Its Glucose Monitor With Oura's Smart Ring -- Barrons.com
IRhythm Data Presented at the American Heart Association 2024 Scientific Sessions Reinforce Clinical and Health Economic Value of Zio Long-Term Continuous Monitoring
Truist Financial Maintains IRhythm Technologies(IRTC.US) With Buy Rating, Maintains Target Price $85
IRhythm Technologies to Participate in the Wolfe Research 2024 Healthcare Conference
BTIG Maintains IRhythm Technologies(IRTC.US) With Buy Rating, Cuts Target Price to $120
IRhythm Technologies, Inc.'s (NASDAQ:IRTC) 30% Jump Shows Its Popularity With Investors
Irhythm Technologies (IRTC) Receives a Buy From BTIG
Morgan Stanley Maintains IRhythm Technologies(IRTC.US) With Buy Rating, Cuts Target Price to $95
Baird Maintains IRhythm Technologies(IRTC.US) With Buy Rating, Cuts Target Price to $79
A Quick Look at Today's Ratings for IRhythm Technologies(IRTC.US), With a Forecast Between $79 to $120